MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARWR — Arrowhead Research Corporation
NasdaqArrowhead Research Corporation
$64.19
-0.60(-0.93%)
- O
- 65.57
- H
- 66.16
- L
- 63.99
- V
- 1.49M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ARWR
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 1, 1995
Employees711
Stock ExchangeNasdaq
Ticker SymbolARWR
Key Financial Statistics
| Market Cap | $9.31B |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.20 - $2,925.00 |
| 52-Week Avg Volume | 603.4K |
| VWAP | $64.54 |
| Transactions | 24,694 |
| Total Recorded Bars | 8,252 days |